Overview
Spine solutions provider's Q4 revenue slightly beat analyst expectations
Adjusted EBITDA for Q4 beat analyst estimates
Surgical revenue grew 21% yr/yr, driven by case volume growth
Outlook
Company expects full-year 2026 revenue to approximate $890 mln
Company increases adjusted EBITDA guidance to $134 mln for 2026
Company expects at least $20 mln of free cash flow for 2026
Result Drivers
SURGICAL REVENUE - Surgical revenue increased by 21% year-over-year, driven by growth in case volumes
NEW SURGEON USERS - Net new surgeon users increased 23% in Q4, reinforcing durable growth
Company press release: ID:nBw6gJrlwa
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Slight Beat*
$213 mln
$211.38 mln (12 Analysts)
Q4 Net Income
-$22 mln
Q4 Adjusted EBITDA
Beat
$33 mln
$30.61 mln (10 Analysts)
Q4 Gross Margin
70%
Q4 Adjusted Gross Margin
71.00%
Q4 Basic EPS
-$0.14
Q4 Operating Income
-$8.82 mln
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)